Targeting epitopes in prostate-specific membrane antigen for antibody therapy of prostate cancer

被引:10
作者
Kinoshita, Y
Kuratsukuri, K
Newman, N
Rovito, PM
Kaumaya, PTP
Wang, CY
Haas, GP
机构
[1] SUNY Upstate Med Ctr, Dept Urol, Syracuse, NY 13210 USA
[2] SUNY Upstate Med Ctr, Dept Med, Syracuse, NY 13210 USA
[3] Ohio State Univ, Dept Obstet & Gynecol, Columbus, OH 43210 USA
[4] VA Med Ctr, Syracuse, NY USA
关键词
antibody; prostate-specific membrane antigen; LNCaP; prostate cancer; antitumor activity; glutamate carboxypeptidase;
D O I
10.1038/sj.pcan.4500835
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Prostate-specific membrane antigen ( PSMA) is a target for immunotherapy of prostate cancer. It has been shown that antibodies against PSMA inhibited the in vivo growth of LNCaP tumor. In the present study, monoclonal antibodies against four epitopes in PSMA were raised. MAb 24.4E6 (IgG1), specific for the epitope ( residues 638 - 657) in PSMA, significantly reduced the growth rate of established LNCaP tumor in SCID mice. Mouse IgG was detected in the tumor of mice treated with 24.4E6, but not with an unrelated MAb. These results suggest that this epitope may be the main target in PSMA for antibody therapy of prostate cancer.
引用
收藏
页码:359 / 363
页数:5
相关论文
共 50 条
[31]   Prostate-Specific Membrane Antigen Targeted Therapy of Prostate Cancer Using a DUPA-Paclitaxel Conjugate [J].
Lv, Qingzhi ;
Yang, Jincheng ;
Zhang, Ruoshi ;
Yang, Zimeng ;
Yang, Zhengtao ;
Wang, Yongjun ;
Xu, Youjun ;
He, Zhonggui .
MOLECULAR PHARMACEUTICS, 2018, 15 (05) :1842-1852
[32]   SaporinToxin-Conjugated Monoclonal Antibody Targeting Prostate-Specific Membrane Antigen Has Potent Anticancer Activity [J].
Kuroda, Kenji ;
Liu, He ;
Kim, Sae ;
Guo, Ming ;
Navarro, Vincent ;
Bander, Neil H. .
PROSTATE, 2010, 70 (12) :1286-1294
[33]   Prostate-Specific Membrane Antigen-Targeted NIR Phototheranostics for Prostate Cancer [J].
Solanki, Krishna ;
Ahmed, Nazeer ;
Srivastava, Nidhi ;
Meher, Niranjan .
ACS APPLIED BIO MATERIALS, 2024, 7 (09) :5861-5884
[34]   Prostate-specific membrane antigen-directed nanoparticle targeting for extreme nearfield ablation of prostate cancer cells [J].
Lee, Seung S. ;
Roche, Philip J. R. ;
Giannopoulos, Paresa N. ;
Mitmaker, Elliot J. ;
Tamilia, Michael ;
Paliouras, Miltiadis ;
Trifiro, Mark A. .
TUMOR BIOLOGY, 2017, 39 (03)
[35]   Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer [J].
Paschalis, Alec ;
Sheehan, Beshara ;
Riisnaes, Ruth ;
Rodrigues, Daniel Nava ;
Gurel, Bora ;
Bertan, Claudia ;
Ferreira, Ana ;
Lambros, Maryou B. K. ;
Seed, George ;
Yuan, Wei ;
Dolling, David ;
Welti, Jon C. ;
Neeb, Antje ;
Sumanasuriya, Semini ;
Rescigno, Pasquale ;
Bianchini, Diletta ;
Tunariu, Nina ;
Carreira, Suzanne ;
Sharp, Adam ;
Oyen, Wim ;
de Bono, Johann S. .
EUROPEAN UROLOGY, 2019, 76 (04) :469-478
[36]   Prostate-specific membrane antigen [J].
Fair, WR ;
Israeli, RS ;
Heston, WDW .
PROSTATE, 1997, 32 (02) :140-148
[37]   Imaging Prostate Cancer: Clinical Utility of Prostate-Specific Membrane Antigen [J].
Kuppermann, David ;
Calais, Jeremie ;
Marks, Leonard S. .
JOURNAL OF UROLOGY, 2022, 207 (04) :769-778
[38]   Prostate-specific membrane antigen expression as a predictor of prostate cancer progression [J].
Perner, Sven ;
Hofer, Matthias D. ;
Kim, Robert ;
Shah, Rajal B. ;
Li, Haojie ;
Moeller, Peter ;
Hautmann, Richard E. ;
Gschwend, Juergen E. ;
Kuefer, Rainer ;
Rubin, Mark A. .
HUMAN PATHOLOGY, 2007, 38 (05) :696-701
[39]   Prostate-Specific Membrane Antigen (PSMA)-Targeted Radionuclide Probes for Imaging and Therapy of Prostate Cancer [J].
Kwon, Hongmok ;
Son, Sang-Hyun ;
Byun, Youngjoo .
ASIAN JOURNAL OF ORGANIC CHEMISTRY, 2019, 8 (09) :1588-1600
[40]   Prostate-specific membrane antigen (PSMA)-ligand positron emission tomography and radioligand therapy (RLT) of prostate cancer [J].
Tateishi, Ukihide .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (04) :349-356